Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
NLG802 is a prodrug of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor indoxomid, which reduces production of kynurenine from tryptophan and potentially increases anti-tumor immune response (PMID: 32422549).
|DrugClasses||IDO1 Inhibitor 12|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Navoximod + NLG802||NLG802 Navoximod||0||1|